Does RITUXIMAB-ABBS Cause Interstitial lung disease? 31 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Interstitial lung disease have been filed in association with RITUXIMAB-ABBS. This represents 0.7% of all adverse event reports for RITUXIMAB-ABBS.
31
Reports of Interstitial lung disease with RITUXIMAB-ABBS
0.7%
of all RITUXIMAB-ABBS reports
3
Deaths
12
Hospitalizations
How Dangerous Is Interstitial lung disease From RITUXIMAB-ABBS?
Of the 31 reports, 3 (9.7%) resulted in death, 12 (38.7%) required hospitalization, and 2 (6.5%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB-ABBS. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB-ABBS Cause?
Off label use (2,167)
Intentional product use issue (273)
Dyspnoea (208)
Pain (205)
Rheumatoid arthritis (202)
Intentional dose omission (196)
Fatigue (195)
Drug ineffective (186)
Hypertension (183)
Infusion related reaction (183)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which RITUXIMAB-ABBS Alternatives Have Lower Interstitial lung disease Risk?
RITUXIMAB-ABBS vs RITUXIMAB-ARRX
RITUXIMAB-ABBS vs RITUXIMAB-PVVR
RITUXIMAB-ABBS vs RIVAROXABAN
RITUXIMAB-ABBS vs RIVASTIGMINE
RITUXIMAB-ABBS vs RIVOTRIL